These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28855598)

  • 41. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?
    Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT
    J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggregation rate of amyloid beta peptide is controlled by beta-content in monomeric state.
    Thu TTM; Co NT; Tu LA; Li MS
    J Chem Phys; 2019 Jun; 150(22):225101. PubMed ID: 31202253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of G33A and G33I mutations on the structures of monomer and dimer of the amyloid-β fragment 29-42 by replica exchange molecular dynamics simulations.
    Lu Y; Wei G; Derreumaux P
    J Phys Chem B; 2011 Feb; 115(5):1282-8. PubMed ID: 21186801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study.
    Minh Thu TT; Huang SH; Tu LA; Fang ST; Li MS; Chen YC
    Neurochem Int; 2019 Oct; 129():104512. PubMed ID: 31374231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Mechanisms of Alzheimer's Biomarker FDDNP Binding to Aβ Amyloid Fibril.
    Parikh ND; Klimov DK
    J Phys Chem B; 2015 Sep; 119(35):11568-80. PubMed ID: 26237080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicity inhibitors protect lipid membranes from disruption by Aβ42.
    Malishev R; Nandi S; Kolusheva S; Levi-Kalisman Y; Klärner FG; Schrader T; Bitan G; Jelinek R
    ACS Chem Neurosci; 2015 Nov; 6(11):1860-9. PubMed ID: 26317327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insights into the Mixture of Aβ24 and Aβ42 Peptides from Atomistic Simulations.
    Nguyen PH; Derreumaux P
    J Phys Chem B; 2022 Dec; 126(50):10689-10696. PubMed ID: 36493347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zn(2+) effect on structure and residual hydrophobicity of amyloid β-peptide monomers.
    Shi H; Kang B; Lee JY
    J Phys Chem B; 2014 Sep; 118(35):10355-61. PubMed ID: 25117080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.
    Lin YS; Bowman GR; Beauchamp KA; Pande VS
    Biophys J; 2012 Jan; 102(2):315-24. PubMed ID: 22339868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
    Lee C; Ham S
    J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of familial mutations on the monomer structure of Aβ₄₂.
    Lin YS; Pande VS
    Biophys J; 2012 Dec; 103(12):L47-9. PubMed ID: 23260058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ
    Saini RK; Shuaib S; Goyal D; Goyal B
    J Biomol Struct Dyn; 2019 Aug; 37(12):3183-3197. PubMed ID: 30582723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity.
    Jin Y; Sun Y; Lei J; Wei G
    Phys Chem Chem Phys; 2018 Jun; 20(25):17208-17217. PubMed ID: 29900443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of A2T and D23N mutations on C99 homodimer conformations.
    Lu Y; Salsbury FR; Derreumaux P
    J Chem Phys; 2022 Aug; 157(8):085102. PubMed ID: 36050011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solid-state NMR sequential assignment of Osaka-mutant amyloid-beta (Aβ1-40 E22Δ) fibrils.
    Huber M; Ovchinnikova OY; Schütz AK; Glockshuber R; Meier BH; Böckmann A
    Biomol NMR Assign; 2015 Apr; 9(1):7-14. PubMed ID: 24395155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zinc binding promotes greater hydrophobicity in Alzheimer's Aβ42 peptide than copper binding: Molecular dynamics and solvation thermodynamics studies.
    Boopathi S; Dinh Quoc Huy P; Gonzalez W; Theodorakis PE; Li MS
    Proteins; 2020 Oct; 88(10):1285-1302. PubMed ID: 32419254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural Characterization of Amyloid β17-42 Dimer by Potential of Mean Force Analysis: Insights from Molecular Dynamics Simulations.
    Dutta M; Chutia R; Mattaparthi VSK
    Protein Pept Lett; 2017; 24(7):650-660. PubMed ID: 28641562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.